AstraZeneca CFO Aradhana Sarin discusses how the pharmaceutical company is broadening its US shareholder base and plans to ...

By Maggie Fick LONDON (Reuters) -AstraZeneca CEO Pascal Soriot looked relaxed standing in the Oval Office on Friday as U.S. President Donald Trump unveiled a medicine deal that will lower drug prices ...

By Bhanvi Satija LONDON, May 18 (Reuters) - Anglo-Swedish drugmaker AstraZeneca said on Monday its hypertension pill baxdrostat had been approved in the United States, offering a new treatment option ...

AstraZeneca makes proposals to cut U.S. drug price cuts CEO Soriot says also considering direct sales to customers AstraZeneca maintains annual outlook Second-quarter sales and profit beat analysts' ...

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has named Rick R. Suarez Senior Vice President, US President and Head of the US BioPharmaceuticals Business Unit. Suarez will lead the execution of the ...

AstraZeneca Unveils $50 Billion US Investment as Pharma Tariff Threat Looms By Ahmed Aboulenein and Maggie Fick WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and ...

US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $18 million to date AstraZeneca has proudly awarded $3.4 million to nonprofit ...